Figure 1: Chemical Structure Of Sevelamer Hydrochloride (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 01)
Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 70710-2058
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 70710-2058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 02)
This text provides information on a study or trial related to the reduction of serum phosphorus levels in patients using Sevelamer Hydrochloride compared to an active control. It indicates the percentage of patients with reduction greater than a certain value (X) from the baseline. The data presented includes the number of patients (N) at various reduction levels in milligrams per deciliter (mg/dL).*
Image (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 03)
Pdp-bottle (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 04)
This text provides information on a medication called Sevelamer hydrochloride in tablet form, with each tablet containing 800 mg of the active ingredient. The dosage instructions and storage conditions are included, suggesting to store the tablets between 20°C to 25°C and protecting them from moisture. The text also mentions Zydus Pharmaceuticals (USA) Inc. as the distributor. The product details like dosage code, container size, and dimensions are listed along with additional information such as the GTIN, SN, LOT, and EXP numbers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
